Uncategorized
Sustained-release intravitreal implant for chronic DME now available in UK
Iluvien, a sustained-release intravitreal implant for the treatment of chronic diabetic macular edema, is now available in the United Kingdom, according to a news release from Alimera Sciences.Furthermore, the U.K.’s National Institute for Health and Care Excellence (NICE), which ruled last year that Iluvien (sustained-release fluocinolone acetonide) did not meet cost-effectiveness thresholds, is scheduled to meet on May 15 to discuss the simple Patient Access Scheme Alimera submitted for the product.